Grace E. ColónPresident and CEO at InCarda Therapeutics Inc
Dr. Colón brings over 25 years’ experience in biopharma, genomics, healthcare and industrial biotechnology. She is CEO of InCarda Therapeutics, a senior advisor (former partner) at New Science Ventures and serves on the board of directors of ProterixBio, Paradigm Diagnostics, PerceptiMed and Cocoon Biotech and on the Advisory Board of the Miller Center for Social Entrepreneurship at Santa Clara University.Previously, she was founding President of the Industrial Products Division at Intrexon Corporation and held various leadership roles at Gilead Sciences. Prior to Gilead, she was VP, Corporate Planning at Affymetrix, where she also served as COO for the International Genomics Consortium. Earlier in her career she was a consultant with McKinsey & Co., where she served clients in healthcare, biotech, high tech and venture capital. Dr. Colón received her Ph.D. from the Massachusetts Institute of Technology and a B.S. degree from the University of Pennsylvania, both in chemical engineering.